UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

What is an ROC curve?

Emergency medicine journal : EMJ, 2017-06, Vol.34 (6), p.357-359

2017

Volltextzugriff (PDF)

Making the invisible visible: the availability and desirability of adherence data in routine CF care- findings from a national questionnaire survey [version 2; peer review: 2 approved]

F1000 research, 2019-01, Vol.8, p.1904-1904

2019

Volltextzugriff (PDF)

Why sample size estimates?

Emergency medicine journal : EMJ, 2018-12, Vol.35 (12), p.755-756

2018

Volltextzugriff (PDF)

Role of habit in treatment adherence among adults with cystic fibrosis

Thorax, 2019-02, Vol.74 (2), p.197-199

2019

Volltextzugriff (PDF)

Understanding patient activation and adherence to nebuliser treatment in adults with cystic fibrosis: responses to the UK version of PAM-13 and a think aloud study

BMC health services research, 2019-06, Vol.19 (1), p.420-420, Article 420

2019

Volltextzugriff (PDF)

Case Report: Dual nebulised antibiotics among adults with cystic fibrosis and chronic Pseudomonas infection

F1000 research, 2017-01, Vol.6, p.2079

2017

Volltextzugriff (PDF)

Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial

Thorax, 2022-05, Vol.77 (5), p.461-469

2022

Volltextzugriff (PDF)

Understanding Pseudomonas status among adults with cystic fibrosis: a real-world comparison of the Leeds criteria against clinicians’ decision

European journal of clinical microbiology & infectious diseases, 2018-04, Vol.37 (4), p.735-743

2018

Volltextzugriff (PDF)

Understanding FEV1 for the purpose of cystic fibrosis registry comparisons: Does bias in annual review FEV1 affect between‐centre comparison within the UK? An analysis of registry data

Journal of evaluation in clinical practice, 2020-02, Vol.26 (1), p.229-235

2020

Volltextzugriff (PDF)

The importance of data issues when comparing cystic fibrosis registry outcomes between countries: Are annual review FEV1 in the UK only collected when subjects are well?

Journal of evaluation in clinical practice, 2018-08, Vol.24 (4), p.745-751

2018

Volltextzugriff (PDF)

Idiopathic pulmonary fibrosis

Thorax, 2012-08, Vol.67 (8), p.742-746

2012

Volltextzugriff (PDF)

Pragmatic criteria to define chronic pseudomonas aeruginosa infection among adults with cystic fibrosis

European journal of clinical microbiology & infectious diseases, 2018-11, Vol.37 (11), p.2219-2222

2018

Volltextzugriff (PDF)

A pragmatic behavior-based habit index for adherence to nebulized treatments among adults with cystic fibrosis

Patient preference and adherence, 2019, Vol.13, p.283-294

2019

Volltextzugriff (PDF)

Prospectively predicting Pseudomonas aeruginosa infection/s using routine data from the UK cystic fibrosis register

Health science reports, 2021-12, Vol.4 (4), p.e381-n/a

2021

Volltextzugriff (PDF)

Using different methods to process forced expiratory volume in one second (FEV1) data can impact on the interpretation of FEV1 as an outcome measure to understand the performance of an adult cystic fibrosis centre: A retrospective chart review

F1000 research, 2018, Vol.7, p.691

2018

Volltextzugriff (PDF)

An intervention to support adherence to inhaled medication in adults with cystic fibrosis: the ACtiF research programme including RCT

Programme grants for applied research, 2021-10, Vol.9 (11), p.1-146

2021

Volltextzugriff (PDF)

Using different methods to process forced expiratory volume in one second (FEV 1) data can impact on the interpretation of FEV 1 as an outcome measure to understand the performance of an adult cystic fibrosis centre: A retrospective chart review

F1000 research, 2018-01, Vol.7

2018

Volltextzugriff (PDF)

Duration of intravenous antibiotic therapy in people with cystic fibrosis

Cochrane database of systematic reviews, 2019-09, Vol.9 (9), p.CD006682

2019

Volltextzugriff (PDF)

Future Discounting Bias and Scenarios Without Lock-Step FEV1/Life Expectancy Coherence May Result in Suboptimal Treatment Recommendations

Chest, 2023-04, Vol.163 (4), p.e193-e194

2023

Volltextzugriff (PDF)

Regarding the article entitled “A smartphone application for reporting symptoms in adults with cystic fibrosis improves the detection of exacerbations: Results of a randomised controlled trial”

Journal of cystic fibrosis, 2020-03, Vol.19 (2), p.e9-e9

2020

Volltextzugriff (PDF)

A comparison of the CFHH criteria against the Leeds criteria in determining the Pseudomonas aeruginosa status among adults with cystic fibrosis

Respiratory medicine, 2020-09, Vol.171, p.106103-106103, Article 106103

2020

Volltextzugriff (PDF)

Development of data processing algorithm to calculate adherence for adults with cystic fibrosis using inhaled therapy – a multi-center observational study within the CFHealthHub learning health system

Expert review of pharmacoeconomics & outcomes research, 2024-07, Vol.24 (6), p.759-771

2024

Volltextzugriff (PDF)

Regarding the articles on home spirometry

Journal of cystic fibrosis, 2022-05, Vol.21 (3), p.e212-e214

2022

Volltextzugriff (PDF)

Future Discounting Bias and Scenarios Without Lock-Step FEV 1 /Life Expectancy Coherence May Result in Suboptimal Treatment Recommendations

Chest, 2023-04, Vol.163 (4), p.e193

2023

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(46)
Dissertationen
(1)

Sprache

Englisch
(47)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

What is an ROC curve?

Making the invisible visible: the availability and desirability of adherence data in routine CF care- findings from a national questionnaire survey [version 2; peer review: 2 approved]

Why sample size estimates?

Role of habit in treatment adherence among adults with cystic fibrosis

Understanding patient activation and adherence to nebuliser treatment in adults with cystic fibrosis: responses to the UK version of PAM-13 and a think aloud study

Case Report: Dual nebulised antibiotics among adults with cystic fibrosis and chronic Pseudomonas infection

Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial

Understanding Pseudomonas status among adults with cystic fibrosis: a real-world comparison of the Leeds criteria against clinicians’ decision

Understanding FEV1 for the purpose of cystic fibrosis registry comparisons: Does bias in annual review FEV1 affect between‐centre comparison within the UK? An analysis of registry data

The importance of data issues when comparing cystic fibrosis registry outcomes between countries: Are annual review FEV1 in the UK only collected when subjects are well?

Idiopathic pulmonary fibrosis

Pragmatic criteria to define chronic pseudomonas aeruginosa infection among adults with cystic fibrosis

A pragmatic behavior-based habit index for adherence to nebulized treatments among adults with cystic fibrosis

Prospectively predicting Pseudomonas aeruginosa infection/s using routine data from the UK cystic fibrosis register

Using different methods to process forced expiratory volume in one second (FEV1) data can impact on the interpretation of FEV1 as an outcome measure to understand the performance of an adult cystic fibrosis centre: A retrospective chart review

An intervention to support adherence to inhaled medication in adults with cystic fibrosis: the ACtiF research programme including RCT

Using different methods to process forced expiratory volume in one second (FEV 1) data can impact on the interpretation of FEV 1 as an outcome measure to understand the performance of an adult cystic fibrosis centre: A retrospective chart review

Duration of intravenous antibiotic therapy in people with cystic fibrosis

Future Discounting Bias and Scenarios Without Lock-Step FEV1/Life Expectancy Coherence May Result in Suboptimal Treatment Recommendations

Regarding the article entitled “A smartphone application for reporting symptoms in adults with cystic fibrosis improves the detection of exacerbations: Results of a randomised controlled trial”

A comparison of the CFHH criteria against the Leeds criteria in determining the Pseudomonas aeruginosa status among adults with cystic fibrosis

Development of data processing algorithm to calculate adherence for adults with cystic fibrosis using inhaled therapy – a multi-center observational study within the CFHealthHub learning health system

Regarding the articles on home spirometry

Real-World Adherence Among Adults With Cystic Fibrosis Is Low: A Retrospective Analysis of the CFHealthHub Digital Learning Health System

Future Discounting Bias and Scenarios Without Lock-Step FEV 1 /Life Expectancy Coherence May Result in Suboptimal Treatment Recommendations

Suchergebnisse filtern